Pfizer Inc | Asian Scientist Magazine | Science, Technology and Medicine News Updates From Asia

Pfizer To Conduct NSCLC Drug Trial In Asia

Pfizer Inc. will conduct a clinical trial of its crizotinib drug, marketed under the trademark Xalkori®, in four Asian countries.

February 18, 2013

Pfizer, Mylan To Team Up On Generics Business In Japan

Pfizer Inc. and Mylan Inc. have signed an agreement to develop, manufacture, distribute, and market generic drugs in Japan.

August 27, 2012

Pfizer & Hisun Pharma To Jointly Develop Off-Patent Generics In China

Pfizer Inc. and Zhejiang Hisun Pharmaceutical have agreed to jointly develop, manufacture, and commercialize off-patent pharmaceutical products in China and global markets.

February 22, 2012

Coalition Aims To Eradicate 10 Neglected Tropical Diseases By 2020

A large coalition of pharmas, governments, and NGOs have announced their goal of eliminating or controlling 10 neglected tropical diseases by 2020.

January 31, 2012

SFJ Pharma To Conduct Phase III Trial Of Pfizer’s Axitinib Adjuvant Treatment In Asia

SFJ Pharma Ltd. will conduct a Phase III clinical trial in Asia of Pfizer’s axitinib for the adjuvant treatment of patients at high risk of recurrent renal cell carcinoma following nephrectomy.

January 10, 2012

Pfizer Animal Health & The Resource Foundation To Train India’s Rural Farmers

Pfizer Animal Health and The Resource Foundation will help to increase the capacity, productivity, and quality of life of rural farmers in India and Latin America.

October 21, 2011

Pfizer Animal Health & Jilin Guoyuan Announce Animal Vaccine Joint Venture In China

Pfizer And Guoyuan have formed a joint venture to expand development, manufacture, and distribution of animal vaccines in China, with an initial focus on swine vaccines.

September 9, 2011